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High-risk human papillomaviruses (HPVs) cause a variety of malignancies of the mucosal epithelium.
However, the local immune evasion strategies used by HPV-transformed cells remain unclear. Here, we
examined the effect of HPV-positive cancer cells on human peripheral blood monocytes, which are
precursors of Langerhans cells, key antigen-presenting cells in the squamous epithelium. HPV-positive
cervical cancer cells and HPV-E6 expressing cells inhibited monocyte differentiation to Langerhans cells
in a contact-dependent manner. Unlike Langerhans cells, monocytes that differentiated in the presence
of HPV16 E6-expressing cells exhibited high levels of endocytic activity. Our results suggest that cells
infected by high-risk HPV evade immune surveillance by blocking the differentiation of monocytes into
competent antigen presenting cells.
& 2013 Elsevier Inc. All rights reserved.Introduction
Cervical cancer represents a major cause of cancer-related
mortality in women worldwide. Human papillomavirus (HPV),
particularly the high-risk types (including HPV16 and HPV18), is
the primary etiologic agent of cervical cancer (zur Hausen, 2009).
Papillomaviruses are double-stranded DNA viruses that replicate
exclusively in stratiﬁed squamous epithelia, using the differentia-
tion of the epithelium to regulate their replication (Doorbar, 2005).
Infection with high-risk HPV can result in integration of the viral
genome into host DNA, which can up-regulate the expression of
E6/E7 through multiple mechanisms (Jeon and Lambert, 1995). If
integration interrupts the viral E2 gene, overexpression of E6 and
E7 proteins occurs due to the loss of E2-mediated transcriptional
repression. As a result, HPV-infected cells with integrated HPV
DNA acquire extended lifespan, retain the capacity to proliferate,
and accumulate mutations attributable to the actions of E6 and E7
proteins (Moody and Laimins, 2010). The E6 and E7 oncogenes are
continuously expressed in human cancer cells and are required for
proliferation and survival of the cells (Goodwin and DiMaio, 2000;
Magaldi et al., 2012).
In order for immune elimination of virally infected cells, effector
T cells must not only recognize viral antigen presenting target
epithelial cells (Gainey et al., 2012), but must also be stimulated by
local dendritic cells (DC) (Zammit et al., 2005; Zammit andll rights reserved.
i).Lefrancois 2006; Wakim et al., 2008; Iijima et al., 2008). Restimula-
tion of memory T cells by local antigen-presenting DCs appears to
be a pre-requisite for the effector functions of T cells. However, the
immunological status and the antigen-presenting function of DCs
within cervical cancer lesions are unclear. Previous studies showed
that cervical intraepithelial neoplasias are greatly depleted of
Langerhans cells (LC) (Hayati and Zulkarnaen, 2007; Jimenez-
Flores et al., 2006; Hubert et al., 2005; Uchimura et al., 2004;
Connor et al., 1999; Viac et al., 1990; Hughes et al., 1988; Le Poole
et al., 2008; Guess and McCance, 2005), which are specialized DCs
found within the stratiﬁed squamous epithelium. However, the
mechanism(s) responsible for LC depletion in these tissues remains
unclear. It has been shown that E6 and E7 down-regulate expres-
sion of chemoattractants, such as IL-8 (Huang et al., 2002), MCP-1/
CCL2 (Kleine-Lowinski et al., 2003) and MIP-3α/CCL20 (Guess and
McCance, 2005). Reduced expression of chemoattractants might
contribute to the absence of LCs in the squamous intraepithelial
lesions. In addition, surface E-cadherin expression is suppressed to
some extent by HPV E6, possibly leading to impaired LC retention
within the infected epidermis (Matthews et al., 2003). However,
because LCs differentiate from a local monocyte precursor within
the stratiﬁed epithelium (as opposed to fully differentiated LCs
migrating from a distal site) (Merad et al., 2002; Ginhoux et al.,
2006), a pertinent question is whether HPV might inhibit LC
differentiation within the epithelial lesion. In this regard, CD14+
monocytes, which can normally differentiate into LCs, have been
reported to accumulate within and around the HPV-positive vulvar
intraepithelial neoplasia, and yet, LC numbers remain low within
the lesion (Terlou et al., 2010).
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on human monocyte differentiation and function and demonstrate
that HPV-expressing cervical cancer cells inhibit the differentia-
tion of monocytes to LC in vitro, and we probe the viral genes
responsible for this inhibition. Further, we examine the functional
consequences of co-cultivation with HPV-positive cancer cells on
antigen-presenting and T cell differentiating functions.Results
High-risk HPV-positive carcinoma cell lines inhibit differentiation of
monocytes into Langerhans cells
In the presence of GM-CSF, IL-4, and TGF-β, primary human
peripheral blood monocytes undergo a differentiation program
in vitro to become LCs (Geissmann et al., 1998). To determine
whether HPV-positive cancer cells affect monocyte differentiation,
we developed an in vitro co-culture system in which human
peripheral blood monocytes are incubated in the presence or
absence of various cancer cell lines in the LC differentiation media,
and then assessed for LC development. In order to prevent out-
growth of cancer cells in our co-cultures, carcinoma cell lines were
UV-irradiated prior to co-incubation with monocytes. After seven
days, monocyte-derived cells were analyzed by ﬂow cytometry for
the expression of LC markers typically used to deﬁne these cells
including CD1a, E-cadherin and MHC class II (HLA-DR). In the
absence of carcinoma cells, differentiation to LCs was very efﬁcient
(∼90% CD1a+/HLA-DR+/E-cadherin+/CD14) (Fig. 1A). Co-culture
with carcinoma cell lines in general reduced LC differentiation.
However, compared to HPV-negative cell lines such as C33A
(cervical) and A431 (epidermoid), which reduced LC differentiation
to ∼50%, HPV-positive cervical cancer cell lines reduced LC differ-
entiation to 17.2% (Caski, HPV16+), or o1% (HeLa, HPV18+) (Fig. 1B).
In addition to the reduction in frequency of LCs, the average total LC
yield, as well as non-LC cell numbers, from four or more donors was
dramatically reduced by the presence of HPV-positive cancer cells
(Fig. 1C). Paraformaldehyde-ﬁxed HPV-positive carcinoma cell lines,
SiHa (HPV16+) and Caski (HPV16+), also inhibited monocyte differ-
entiation to LCs (Fig. 1D), suggesting that the inhibition is not likely
to be due to residual secretion of soluble factors from UV-treated
HPV-positive carcinoma cells. In addition, live HPV-positive HeLa
cells transduced with HPV16 E6 and E7 also inhibited LC differ-
entiation as well as recovery of non-LCs (Fig. 1E). Collectively, these
data demonstrate that HPV-positive cancer cell lines preferentially
inhibit LC differentiation and induce death of differentiating cells in
general when co-cultured with monocyte precursors.
Monocyte inhibition requires high density of HPV-positive cells
The epithelial layer in a carcinoma in situ would be expected to
provide a microenvironment in which the monocytes would
encounter a very high density of transformed keratinocytes.
Indeed, inhibition of monocyte differentiation to LCs required a
high density of cervical carcinoma cells (3106 cells/T12.5 ﬂask),
because incubation of monocytes with a low density of cancer cells
(0.5106 cells/ﬂask) did not block LC differentiation (Fig. 2). These
data indicated that HPV-positive carcinoma cells above a certain
density threshold appeared to robustly inhibit monocyte differ-
entiation to LCs.
Ectopic HPV16 E6 expression inhibits monocyte-to-LC differentiation
Cervical carcinoma cells express HPV E6 and E7 oncogenes.
To determine if E6 and E7 expression is sufﬁcient to reproduce the
inhibitory effects of HPV-positive cancer cell lines on monocytedifferentiation, the HPV-negative C33A cervical carcinoma cell line
was transduced with E6 and E7 genes from high-risk HPV16 to
generate C33A/E6/E7 cells. Monocytes incubated with the parental
C33A differentiated into LCs (31.8% LC), whereas incubation with
C33A/E6/E7 cells reduced LC frequency (to 12.6% LC) (Fig. 3A). This
inhibitory effect was not due to general toxicity of the E6/E7 cell
line, since differentiation of monocytes into macrophages (CD1a
HLADR+) (in the presence of GM-CSF alone) was the same
regardless of the presence of C33A cells expressing E6 and E7
(Fig. 3A).
Next, to determine if cell-to-cell contact was required for
inhibitory effect of HPV-positive cancer cells on monocyte differ-
entiation, monocytes were co-cultured with C33A cells or C33A/
E6/E7 cells, either together or separated by the permeable mem-
brane in a Transwell insert (Fig. 3B). While direct cell contact
reduced LC frequency from 34% to 13% in an E6/E7-dependent
manner, Transwell separation completely blocked the ability of
C33A/E6/E7 to inhibit monocyte differentiation into LCs (Fig. 3B).
These results indicated that cell-to-cell contact is required for the
inhibitory effect of E6/E7-expressing cancer cells.
Next, we tested the individual ability of E6 and E7 to inhibit
monocyte differentiation. Human peripheral blood monocytes
were cultured in the presence of C33A transduced with HPV 16
E6 (C33A/E6), E7 (C33A/E7) or both (C33A/E6/E7). A signiﬁcant
and comparable reduction in LC number (Fig. 3C) was observed in
monocytes cultured with C33A expressing E6 or E6/E7, but not E7
alone. Expression levels of the transduced genes were conﬁrmed
by quantitative RT-PCR (Fig. 3D). These data indicated that, albeit
much less efﬁcient than HPV-transformed cervical carcinoma cell
lines (Fig. 1), high-risk HPV E6 is speciﬁcally capable of inhibiting
monocyte-to-LC differentiation.
Previous studies indicate that surface E-cadherin expression is
suppressed to some extent by HPV E6, possibly leading to
impaired LC retention within the infected epidermis (Matthews
et al., 2003). However, we did not observe signiﬁcant changes in
the E-cadherin levels between Caski cells (HPV16+) compared to
HaCaT cells (HPV-negative keratinocyte cells line), and between
control HaCaT cells compared to HaCaT cells expressing E6, E6+E7
or (Fig. 3E). Thus, E-cadherin downregulation is unlikely to explain
LC blockade by E6 in our experimental setting.HPV16 E6 promotes endocytic uptake of antigens by differentiated
cells
In addition to blocking LC differentiation, co-culture of mono-
cytes with cancer cells expressing E6 may cause them to adopt an
altered functional state. To determine if this is the case, we
compared the capabilities of E6-conditioned LC-like cells to take
up antigens. To this end, the extent of endocytic uptake of FITC-
dextran was compared between LC-like cells derived in the
presence of C33A, C33A/E6 or C33A/E6/E7. Highly phagocytic
macrophages were included as a positive control. Flow cytometric
analysis indicated that only a small fraction of monocytes cultured
alone or in the presence of C33A cells took up FITC-dextran, and
the amount taken up by these cells was low. In contrast, a majority
of monocytes cultured in the presence of C33A cells expressing E6
or E6/E7 took up high levels of FITC-dextran (Fig. 4). Even the non-
LC cells (CD1a HLA-DR+) exposed to C33A cells expressing HPV
E6 showed similarly high levels of endocytic activity. Incubation of
cells with FITC-dextran at 4 1C resulted in no positive signals,
indicating that an active endocytosis process, and not surface
adhesion, is responsible for the observed FITC signal. These data
indicated that monocytes that differentiate in the presence of HPV
E6 expressing cancer cells exhibit an altered phenotype from wild-
type LC in being more endocytic.
Fig. 1. High-risk HPV-positive cancer cell lines inhibit LC generation from human CD14+ monocytes. (A) CD14+ monocytes puriﬁed from human buffy coats were
incubated in the presence of GM-CSF/IL-4/TGF-β (LC condition) or of GM-CSF (macrophage condition) for 7 days, and stained for LC markers (CD1a, E-cadherin, HLA-DR) and
a monocyte marker (CD14). Red histograms indicate expression of E-cadherin or CD14 in the indicated condition, while gray histograms indicate expression in the other.
(B) Puriﬁed monocytes were co-incubated with UV-treated HPV-negative (C33A and A431) or HPV-positive cancer cell lines (CaSki, HeLa, SiHa and HPV16 E6/E7-transduced
HeLa), and analyzed for expression of CD1a and HLA-DR. (C) The average total numbers of differentiated LC (CD1a+ HLA-DR+) and non-LC (CD1a) obtained from at least four
donors from co-culture with the indicated cancer cell lines are depicted. Error bars indicate standard error of the mean (SEM). (D) and (E) CD14+ monocytes were co-
incubated with PFA-ﬁxed (D) or live (E) HPV-negative (C33A, A431) or high-risk HPV-positive cell lines (SiHa and CaSki or HPV16 E6/E7-transduced HeLa) in the presence of
GM-CSF/IL-4/TGF-β for 7 days. The average total numbers of differentiated LC (CD1a+ HLA-DR+) and non-LC (CD1a) obtained from at least four donors from co-culture with
the indicated cancer cell lines are depicted.
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Immune elimination of virally-infected cells requires robust
CD8 T cell responses and a population of local DCs to elicit recall
responses from effector T cells (Zammit et al., 2005; Zammit and
Lefrancois, 2006; Wakim et al., 2008). A number of studies have
established the paucity of Langerhans’ cells within cervical cancer
and precancerous lesions, but the molecular basis for this defect is
not well understood. Our data demonstrate that HPV-transformed
cancer cell lines directly inhibited the ability of monocytes, the
precursor for LCs in the squamous epithelial layer, to differentiate
into antigen-presenting LCs. This inhibition required cell contact
between HPV-positive cancer cells and monocytes. This effect was
likely mediated via cell surface interactions as even UV or
formaldehyde-killed HPV containing cells retained full repressive
activity. This activity also depended on the HPV E6 but not E7
oncogenes. Further, monocyte-derived LCs that were exposed to
cells expressing HPV-16 E6 acquired higher levels of endocytic
capacity compared to those differentiated in the presence of
parental cell line.
Our data suggest that monocytes within the HPV-positive
lesions fail to differentiate into antigen presenting cells and failto support effector T cell recall response in situ. Currently, the
mechanism by which high-risk HPV E6 protein exerts inhibitory
effects on monocyte differentiation is unknown. E6 likely mediates
the inhibition of monocyte differentiation via a surface expressed
factor, since cell-to-cell contact was required for E6-expressing
cells to inhibit monocyte differentiation to LCs. In addition to
blocking differentiation, HPV-positive cancer cell lines also
appeared to induce death of precursor monocytes as well as
differentiating cells, resulting in general decrease in cell yield
(Fig. 1). Future studies are needed to identify the E6 target(s)
responsible for inhibition of monocyte-to-LC transition.
Our ﬁndings reveal an important axis of immunosuppression
by HPV-infected cells, at the level of differentiation of antigen-
presenting cells. Inhibition of immunosurveillance enforced by
blockade of LC differentiation provides the virus with the chance
to replicate in a more protected environment than would exist in
the normal stratiﬁed squamous epithelium. Thus, in addition to
the previously-described mechanisms of LC exclusion including
impairment in recruitment and retention of LCs, blockade of LC
differentiation within the cervical intraepithelial neoplasia could
contribute to immune evasion of HPV-infected cells. As a conse-
quence of these viral evasion strategies, HPV-infected keratinocytes
Fig. 2. Block of monocyte-to-LC differentiation by cancer cells occurs at high density. Differentiation of LC from CD14+ human monocytes (1106 cells/ﬂask) in the
presence of low (0.5106 cells/ﬂask) or high (3106 cells) densities of cancer cell lines (C33A cells or CaSki cells) was compared. On day 7, expression levels of CD1a and
HLA-DR were analyzed by FACS. These data are representative of at least three separate experiments.
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that eventually lead to carcinogenic progression. Future strategies to
restore LC differentiation in the HPV-infected cervical intraepithelial
neoplasia may be key to successful implementation of immunother-
apeutic intervention against HPV infections and the cancers
they cause.Materials and methods
Cell culture
SiHa and C33A cells were purchased from American Type
Culture Collection (ATTC, Manassas, VA). HeLa-Sen2 cells (referred
to as HeLa throughout the paper), a clonal cell line of HeLa cells
selected for sensitivity to SV40 infection, were described pre-
viously (Goodwin et al., 2000). HeLa, SiHa, and C33A cells were
cultured in Dulbecco's MEM (DMEM) with 10% fetal calf serum
(FCS) (Sigma, St. Louis, MO), 100 U/ml penicillin, 100 μg/ml strep-
tomycin (Invitrogen). CaSki cells were obtained from Michael Reiss
(University of Medicine and Dentistry of New Jersey) and cultured
in RPMI-1640 with 10% FCS (Sigma, St. Louis, MO), 100 U/ml
penicillin, 100 μg/ml streptomycin.Transduction of HPV oncogenes into C33A cells
To generate cells that stably express exogenous HPV16 E6 and
HPV16 E7, C33A cells were ﬁrst infected with concentrated LXSN
or LXSN 16E6 retroviral stocks prepared as described (DeFilippis
et al., 2003) and selected with 350 μg/ml G418 for nine days. Cells
were then infected with concentrated RVY or RVY 16E7 retrovirus
and selected in 200 μg/ml hygromycin for 12 days (DeFilippis et al.,2003) Following selection, cells were maintained in the presence
of 175 μg/ml G418 and 100 μg/ml hygromycin.
Generation of monocyte-derived LCs and macrophages
Peripheral blood mononuclear cells (PBMCs) were isolated
by Ficoll density gradient centrifugation (Ficoll-Paque™ Plus, GE
Healthcare, Waukesha, USA) from buffy coats of healthy anon-
ymous donors (New York Blood Center, New York, NY). CD14+
monocytes were puriﬁed from PBMC by using a MACS CD14
isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany). After
elution from the Midi MACS LS columns, CD14+ monocytes were
cultured (2106 cells per T12.5 ﬂask) in media consisting of RPMI
1640 medium (Invitrogen, Carlsbad, CA) supplemented with 10%
FCS, 100 U/ml penicillin, 100 μg/ml streptomycin, along with
50 ng/ml GM-CSF, 20 ng/ml human IL-4 and 10 ng/ml TGF-β (for
LC generation), or 10 ng/ml GM-CSF (for macrophage generation).
All cytokines were purchased from PeproTech, Rocky Hill, NJ.
The culture medium was replaced with fresh medium containing
cytokines on day 3, and were incubated for additional 3–4 days at
37 1C and 5% CO2.
Preparation of HPV-negative and HPV-positive cancer cell lines for the
co-culture with CD14+ monocytes
Sub-conﬂuent HPV-negative (C33A and A431) and HPV-
positive cell lines (SiHa, HeLa and CaSki) cells were harvested
following trypsin treatment. These cells were seeded in 6 well
plates at the concentration of 2106 cells/ml and then UV
inactivated by exposure to 1 J/cm2 UV light once with a Stratlinker
UV cross-linker (Stratagene). These cells (2106 cells) were added
to a T12.5 ﬂask containing CD14+ monocytes (12106 cells) at
day 0 of the co-culture (2 ml of total volume in T12.5 ﬂask). For
Fig. 3. High-risk HPV16 E6 but not E7 impairs the differentiation of LCs from blood CD14+ monocytes in a contact-dependent manner. CD14+ monocytes were co-
incubated with UV-treated HPV C33A cells containing the empty vector (C33A) or HPV16 E6 and E7-transduced C33A cells in the presence of GM-CSF/IL-4/TGF-β
(LC condition) or GM-CSF (Macrophage condition) for 7 days. Cells were analyzed by ﬂow cytometry for the expression of CD1a and HLA-DR. (B) CD14+ monocytes were co-
incubated with UV-treated transduced C33A cells either together or separately in Transwell. The average numbers of differentiated CD1a+ HLA-DR+ LCs obtained from at
least three donors are depicted. (C) CD14+monocytes were co-incubated with UV-treated vector-transduced or HPV16 E6 and/or E7-transduced C33A cells in the presence of
GM-CSF/IL-4/TGF-β for 7 days. The average numbers of LCs cultured in the presence of C33A transduced with the indicated viral genes obtained from at least three donors are
depicted. (D) Expression levels of HPV16 E6 and/or E7 in C33A transduced with the indicated viral genes were analyzed by quantitative RT-PCR. (E) C33A, Caski, HaCaT or
HaCaT expression HPV16 E6 and/or E7 were stained with antibody to E-cadherin or isotype control. Error bars indicate SEM.*, po0.05; **, po0.01;***, po0.001.
Fig. 4. Increased phagocytic capacity of monocytes differentiated in the presence of HPV16 E6-transduced cell line. CD14+ monocytes were co-incubated with UV-
irradiated HPV-negative (C33A), HPV16 E6 C33A cells, or HPV16 E6+E7 C33A cells in the presence of GM-CSF/IL-4/TGF-β (LC condition) or GM-CSF (Macrophage condition)
for 7 days. (A) Differentiated monocytes were incubated with FITC-Dextran for 1 h at 37 1C or 4 1C. Phagocytic activity of CD1a+HLA-DR+ (upper row) and CD1a HLA-DR+
(bottom row) populations at 37 1C (red dots) and 4 1C (blue dots) was analyzed by ﬂow cytometry. These data were representative of three separate experiments.
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trypsin, washed in complete media, suspended in 4% paraformal-
dehyde in phosphate-buffered saline (PBS) and incubated for
10 min at ambient temperature (no UV treatment was included
prior to ﬁxation). In some experiments, live cancer cells were used.
The cells were then washed with culture media three times prior
to addition to monocyte co-culture.
Flow cytometry
Phenotypic analysis of monocyte-derived cells by ﬂow cyto-
metry was performed using the following antibodies that were
directly conjugated to various ﬂuorescent dyes: CD1a (HI149),
HLA-DR (L243), CD45 (H130), CD3 (UCHT1), CD4 (RPA-T4) E-
cadherin (67A4) and CD14 (61D3) (Biolegend and eBioscience).
Dead cells were excluded by staining with 7-AAD (Biolegend).
After ﬂow cytometry on a LSR II ﬂow cytometer (Becton Dick-
inson), the results were analyzed using the FlowJo software (Tree
Star, Ashland, OR).
Endocytosis assay
Differentiated monocyte-derived LC or macrophages generated
in the presence of C33A cells or HPV16 E6 and/or E7 transduced
C33A cells were incubated with 0.5 mg/ml Fluorescein–conjugated
Dextran (70,000 MW, Anionic, Invitrogen) for 1 h at 37 1C or 4 1C.
After incubation, ice-cold FACS buffer (5% FCS, 0.09% NaN3 in PBS)
containing 0.4% trypan blue was added to quench FITC-Dextran on
the cell surface, and the cells were incubated for 10 min on ice to
stop the endocytic activity. The frequency of FITC+CD1a+HLA-DR+
and FITC+CD1aHLA-DR+ cells was analyzed by ﬂow cytometry.
Monocyte differentiation using the Transwell system
CD14+ monocytes (2106 cells) were added to upper well or
lower well of 0.4 mm pore, polyester membrane, 6-well tissue
culture inserts (Costar, Cambridge, MA, USA) in 1 ml of 10% FCS
RPMI1640, with cancer cell lines (2106 cell/ml) in the lower or
upper well, respectively. CD14+ monocytes and the cancer cells
were cultured separately in the presence of 50 ng/ml GM-CSF,
20 ng/ml human IL-4 and 10 ng/ml TGF-β for 7 days. Differentiated
LCs from upper or lower well were collected for the analysis of cell
surface CD1a and HLA-DR by ﬂow cytometry.Acknowledgment
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